FDA greenlights Sentrian’s Remote Patient Intelligence solution
Sentrian's RPI is not subject to further FDA regulatory requirements at this time, and the company can immediately begin marketing its solution in the U.S.
CareMore, STSI and Sentrian launch COPD clinical trial
The study's objective is to determine whether Sentrian's technology can detect patient deterioration in advance of an acute event.
Sentrian raises $12M for its remote patient intelligence platform
The company provides a cloud-based remote patient monitoring and analytics solution that promises to reduce preventable hospital admissions.